Chong Kun Dang Pharmaceutical Corp. (KOSE: A185750)
Health Care · Pharmaceuticals · KR
₩65,200.00
+0.46% today · -19.5% 1Y
Chong Kun Dang Pharmaceutical Corp. (KOSE: A185750) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $637.89M.
Over the last twelve months the share price has lost 19.5%, trading between 63.00K and 98.10K.
Tweenvest scores Chong Kun Dang Pharmaceutical Corp. across four factors: quality 84/100, value 72/100, dividend 30/100. Its strongest factor is quality.
A185750 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $637.89M
- Revenue (TTM)
- $1.15B
- P/E
- 10.91
- EPS
- 5,977.21
- Dividend yield
- 0.77%
- Beta (5Y)
- 0.24
- 52-week high
- ₩98,100.00
- 52-week low
- ₩63,000.00
- Avg volume (3M)
- —
- Shares outstanding
- 13.18M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Senores Pharmaceuticals LimitedNSEI: SENORES | $645.55M | Rs1,349.60 | -0.41% |
| Jiangsu Lianhuan Pharmaceutical Co., Ltd.SHSE: 600513 | $642.17M | CN¥15.09 | +2.17% |
| Zhejiang Wecome Pharmaceutical Company LimitedSZSE: 300878 | $638.70M | CN¥30.16 | -2.39% |
| IOL Chemicals and Pharmaceuticals LimitedBSE: 524164 | $638.54M | Rs209.45 | +2.55% |
| Henan Taloph Pharmaceutical Stock Co.,LtdSHSE: 600222 | $633.29M | CN¥7.89 | -1.74% |
| Wuhan Hvsen Biotechnology Co.,Ltd.SZSE: 300871 | $630.42M | CN¥21.10 | +1.01% |
| LanZhou Foci Pharmaceutical Co.,Ltd.SZSE: 002644 | $628.82M | CN¥8.26 | +1.47% |
| Chimin Health Management Co., Ltd.SHSE: 603222 | $617.71M | CN¥8.07 | -2.42% |
Figures last refreshed Oct 4, 2026.